? RESOURCE CORE (RC) 3 The goals of the Biostatistics and Data Management Core [(BDMC, henceforth termed Research Core (RC)-3)] are to provide: 1) biostatistical support and expertise; and 2) centralized research information services to ensure ready access and superior data quality to the OAIC. The Core will greatly facilitate data sharing and integrated analyses within the OAIC. Importantly, RC3 develops and implements services not available elsewhere at UTHSCSA. Instead, it will capitalize on the aging-related biostatistical and informatics expertise of the Core team. RC3 provides three innovative and value-added features. (1) To further improve biostatistics support specifically applicable for aging research, Dr. Gelfond (Core Leader) will develop new statistical methods related to survival analysis, latent trajectory models, and comparative genomics in collaboration with OAIC investigators. Dr. Gelfond has substantial experience in directing and developing statistical analyses as well as collaborative experience with key OAIC supported faculty. These new methods are motivated by and required for optimal analyses of the developmental and pilot project data. All these methods will have broader applications in aging research. (2) The Core supports an innovative informatics Developmental Project (DP3) that will identify cohorts within the local community that can be well-suited for clinical trials focused on aging research. Additionally, DP3 will provide access to extensively and appropriately phenotyped de-identified data from UTHSCSA-affiliated clinics that will be available for retrospective studies. (3) The Core will utilize novel collaborative models, developed by the Core Leader, which will promote efficient operations and help track research productivity outcomes, such as publications and funded proposals. The RC3 has four achievable Specific Aims: 1) Provide all biostatistical support and expertise for the OAIC, including study design and planning; protocol development; creation of new analytical approaches; interpretation of study results; and preparation of reports, manuscripts, and presentations; 2) Provide OAIC projects and investigators with state-of-the-art research informatics tools for development of cohorts for trials with aging outcomes, de-identified data to support pilot data for clinical trials development, and tools for efficient clinical trial data collection and management; 3) Contribute expertise, didactics, and hands-on training for analyses of data specific to aging research, as well as education and mentorship of OAIC trainees; and 4) Ensure the success of the Core, continually assess Core utilization and quality, assess research standards and Core outcomes, and leverage assessments for Aims 1, 2, and 3.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
1P30AG044271-01A1
Application #
8878944
Study Section
Special Emphasis Panel (ZAG1-ZIJ-8 (J1))
Project Start
Project End
Budget Start
2015-06-15
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$62,875
Indirect Cost
$22,378
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Salmon, Adam B; Dorigatti, Jonathan; Huber, Hillary F et al. (2018) Maternal nutrient restriction in baboon programs later-life cellular growth and respiration of cultured skin fibroblasts: a potential model for the study of aging-programming interactions. Geroscience 40:269-278
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21
Sills, Aubrey M; Artavia, Joselyn M; DeRosa, Brian D et al. (2018) Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Am J Primatol :e22927
Noël, Polly Hitchcock; Wang, Chen-Pin; Finley, Erin P et al. (2018) Provider-Related Linkages Between Primary Care Clinics and Community-Based Senior Centers Associated With Diabetes-Related Outcomes. J Appl Gerontol :733464818782853
Reveles, Kelly R; Mortensen, Eric M; Koeller, Jim M et al. (2018) Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans. Pharmacotherapy 38:349-356
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Arora, Sukeshi Patel; Mahalingam, Devalingam (2018) Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol 9:170-179
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ipson, B R; Fletcher, M B; Espinoza, S E et al. (2018) Identifying Exosome-Derived MicroRNAs as Candidate Biomarkers of Frailty. J Frailty Aging 7:100-103
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :

Showing the most recent 10 out of 22 publications